Delcath Systems, Inc. Share Price
DCTHDelcath Systems, Inc. Stock Performance
Open $10.22 | Prev. Close $10.36 | Circuit Range N/A |
Day Range $10.22 - $10.57 | Year Range $8.13 - $18.23 | Volume 32,430 |
Average Traded $10.44 |
Delcath Systems, Inc. Share Price Chart
About Delcath Systems, Inc.
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. The company was founded in 1987 and is headquartered in New York, New York.
Delcath Systems, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Jan-26 | $10.22 | $10.46 | +0.00% |
06-Jan-26 | $10.22 | $10.46 | +1.85% |
05-Jan-26 | $10.06 | $10.27 | +3.32% |
02-Jan-26 | $10.05 | $9.94 | -1.44% |
31-Dec-25 | $10.07 | $10.09 | -0.44% |
30-Dec-25 | $10.25 | $10.13 | -0.44% |
29-Dec-25 | $10.24 | $10.18 | -1.12% |
FAQs on Delcath Systems, Inc. Share Price
Can I buy Delcath Systems, Inc. shares in India?
What is the share price of Delcath Systems, Inc.?
What is the 5 year returns of Delcath Systems, Inc.?
What are the high & low stock price of Delcath Systems, Inc. today?
What is the 52-week high and low of Delcath Systems, Inc. stock?